Drug Type Small molecule drug |
Synonyms AR targeted small molecule (ReviR) |
Target |
Action antagonists |
Mechanism AR antagonists(Androgen Receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bulbo-Spinal Atrophy, X-Linked | Preclinical | United States | 25 Nov 2024 |